Works matching DE "PHARMACEUTICAL industry mergers"
Results: 132
Innovations and Merger Decisions in the Pharmaceutical Industry.
- Published in:
- Review of Industrial Organization, 2001, v. 19, n. 2, p. 181, doi. 10.1023/A:1011144517789
- By:
- Publication type:
- Article
Giants wrestle over ImClone.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 12, p. 1323, doi. 10.1038/nbt1208-1323b
- By:
- Publication type:
- Article
Big pharma swallows biotech's pride.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 9, p. 955, doi. 10.1038/nbt0908-955
- By:
- Publication type:
- Article
Pfizer jettisons Esperion.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 7, p. 724, doi. 10.1038/nbt0708-724
- By:
- Publication type:
- Article
A walk through the Valley of Death.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 7, p. 833, doi. 10.1038/nbt0708-833
- By:
- Publication type:
- Article
Genentech makes its first-ever acquisition.
- Published in:
- Nature Biotechnology, 2007, v. 25, n. 1, p. 4, doi. 10.1038/nbt0107-4
- By:
- Publication type:
- Article
A billion dollar punt.
- Published in:
- 2006
- Publication type:
- Editorial
European pharma consolidation generates quality spinoffs.
- Published in:
- Nature Biotechnology, 2006, v. 24, n. 12, p. 1458, doi. 10.1038/nbt1206-1458
- By:
- Publication type:
- Article
Michigan's next wave of biopharmaceutical entrepreneurship.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 9, p. 1109, doi. 10.1038/nbt0903-1109
- By:
- Publication type:
- Article
Changing partners.
- Published in:
- 2002
- Publication type:
- Editorial
Pfizer?Pharmacia merger bodes ill for biotech?
- Published in:
- Nature Biotechnology, 2002, v. 20, n. 9, p. 857, doi. 10.1038/nbt0902-857
- By:
- Publication type:
- Article
SETTING THE “RIGHT” GOAL: POST M&A INNOVATION PERFORMANCE AND GOAL ORIENTATION.
- Published in:
- Business: Theory & Practice, 2020, v. 21, n. 2, p. 555, doi. 10.3846/btp.2020.12083
- By:
- Publication type:
- Article
So Tell Me Again, Why Are We Doing This?
- Published in:
- Bio-IT World, 2010, v. 9, n. 1, p. 12
- By:
- Publication type:
- Article
News briefing: 18 March 2010.
- Published in:
- Nature, 2010, v. 464, n. 7287, p. 330, doi. 10.1038/464330a
- Publication type:
- Article
Pharmaceutical companies join forces on HIV.
- Published in:
- Nature, 2009, v. 458, n. 7241, p. 950, doi. 10.1038/458950b
- By:
- Publication type:
- Article
Merck strengthens drug pipeline in rival takeover.
- Published in:
- Nature, 2009, v. 458, n. 7235, p. 137, doi. 10.1038/458137a
- Publication type:
- Article
Loretta Cangialosi.
- Published in:
- Financial Executive, 2011, v. 27, n. 2, p. 72
- Publication type:
- Article
Perpetuating the Pharmaceutical Pipeline.
- Published in:
- 2003
- By:
- Publication type:
- Interview
REFLECTING On a MEGA-MERGER.
- Published in:
- 2001
- By:
- Publication type:
- Interview
IN NEED OF TREATMENT? MERGER CONTROL, PHARMACEUTICAL INNOVATION, AND CONSUMER WELFARE.
- Published in:
- Journal of Legal Medicine, 2000, v. 21, n. 3, p. 271, doi. 10.1080/01947640050174813
- By:
- Publication type:
- Article
Big pharma's mega-mergers contribute to growth.
- Published in:
- Australian Journal of Pharmacy, 2010, v. 91, n. 1077, p. 52
- Publication type:
- Article
Global Merger: MANAGING STRATEGIC CHANGE IN LOCAL SUBSIDIARIES.
- Published in:
- Management of Organizations: Systematic Research, 2004, n. 29, p. 89
- By:
- Publication type:
- Article
Merger mania: mergers and acquisitions in the generic drug sector from 1995 to 2016.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Roche buys $1 billion majority stake in Foundation.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 3, p. 155, doi. 10.1038/nrd4568
- By:
- Publication type:
- Article
Market watch: Biopharma deal-making in 2014: a record year for M&A value.
- Published in:
- Nature Reviews Drug Discovery, 2015, v. 14, n. 2, p. 84, doi. 10.1038/nrd4536
- By:
- Publication type:
- Article
The Uncertainties Created by Relying on the Vague ‘Competition on the Merits’ Standard in the Pharmaceutical Sector: The Italian Pfizer/Pharmacia Case.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
A Comparative Study of Pre- and Post-Merger Financial Performances of Selected Pharmaceutical Companies in India.
- Published in:
- IUP Journal of Business Strategy, 2015, v. 12, n. 2, p. 7
- By:
- Publication type:
- Article
Shire acquires NPS Pharmaceuticals for $5.2 billion.
- Published in:
- Optometry Times, 2015, v. 7, n. 2, p. 18
- Publication type:
- Article
Acquisition Integration and Productivity Losses in the Technical Core: Disruption of Inventors in Acquired Companies.
- Published in:
- Organization Science, 2006, v. 17, n. 5, p. 545, doi. 10.1287/orsc.1060.0207
- By:
- Publication type:
- Article
Pfizer aborts Allergan deal.
- Published in:
- TCE: The Chemical Engineer, 2016, n. 899, p. 17
- Publication type:
- Article
Pfizer is world's biggest drug firm after swallowing Allergan.
- Published in:
- TCE: The Chemical Engineer, 2015, n. 894/895, p. 17
- Publication type:
- Article
In a rare deal, Shire buys Dyax.
- Published in:
- TCE: The Chemical Engineer, 2015, n. 894/895, p. 7
- Publication type:
- Article
Teva buying Allergan Generics for US$40.5bn.
- Published in:
- TCE: The Chemical Engineer, 2015, n. 891, p. 8
- Publication type:
- Article
Pfizer to buy Hospira in US$17bn deal.
- Published in:
- TCE: The Chemical Engineer, 2015, n. 885, p. 6
- Publication type:
- Article
Actavis buys Botox maker Allergan for US$66bn.
- Published in:
- TCE: The Chemical Engineer, 2014, n. 882, p. 8
- Publication type:
- Article
UK must ward off pharmageddon.
- Published in:
- TCE: The Chemical Engineer, 2014, n. 876, p. 3
- By:
- Publication type:
- Article
Sun Pharma buys Ranbaxy for US$4bn.
- Published in:
- TCE: The Chemical Engineer, 2014, n. 875, p. 12
- Publication type:
- Article
Actavis buys Forest for US$25bn.
- Published in:
- TCE: The Chemical Engineer, 2014, n. 873, p. 8
- Publication type:
- Article
Pharma consolidation continues.
- Published in:
- TCE: The Chemical Engineer, 2010, n. 826, p. 6
- Publication type:
- Article
Fourth time lucky: Roche seals deal on Genentech merger.
- Published in:
- TCE: The Chemical Engineer, 2009, n. 814, p. 5
- Publication type:
- Article
Merck and Schering-Plough to merge.
- Published in:
- TCE: The Chemical Engineer, 2009, n. 814, p. 5
- Publication type:
- Article
Takeda buys Millennium Pharma.
- Published in:
- TCE: The Chemical Engineer, 2008, n. 803, p. 8
- Publication type:
- Article
Big drug company created.
- Published in:
- Nature, 1989, v. 338, n. 6217, p. 610, doi. 10.1038/338610a0
- By:
- Publication type:
- Article
What to Know About CROs.
- Published in:
- Applied Clinical Trials, 2012, p. 16
- By:
- Publication type:
- Article
Enough Speculation, Time to Act.
- Published in:
- Applied Clinical Trials, 2011, v. 20, n. 3, p. 10
- By:
- Publication type:
- Article
M&A in the Pharma Industry.
- Published in:
- Applied Clinical Trials, 2010, v. 19, n. 11, p. 36
- By:
- Publication type:
- Article
Agreements.
- Published in:
- Applied Clinical Trials, 2002, v. 11, n. 3, p. 87
- Publication type:
- Article
News update.
- Published in:
- Applied Clinical Trials, 2000, v. 9, n. 2, p. 12
- Publication type:
- Article
Merger of Glaxo Wellcome and SmithKline Beecham creates pharmaceutical giant.
- Published in:
- Nature, 2000, v. 403, n. 6767, p. 232, doi. 10.1038/35002148
- By:
- Publication type:
- Article
Drugs merger seeks strength in breadth.
- Published in:
- Nature, 1998, v. 391, n. 6668, p. 621, doi. 10.1038/35449
- By:
- Publication type:
- Article